Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,597 | -253,210 | -170,744 | -89,869 | -479,743 |
| Depreciation Amortization | 42,294 | 31,677 | 20,886 | 9,738 | 31,936 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 341,729 |
| Accounts receivable | 14,308 | 67,136 | 52,200 | 52,807 | -13,170 |
| Accounts payable and accrued liabilities | -6,000 | -10,737 | -2,819 | -9,569 | -2,755 |
| Other Working Capital | -113,818 | -58,618 | -43,919 | -12,600 | -73,555 |
| Other Operating Activity | 122,612 | 50,864 | 27,082 | -5,169 | 231,450 |
| Operating Cash Flow | $30,799 | $-172,888 | $-117,314 | $-54,662 | $35,892 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 219,992 | 120,894 | -12,862 | 81,856 | 315,525 |
| PPE Investments | -11,955 | -9,453 | -6,130 | -1,772 | -35,120 |
| Net Acquisitions | N/A | -7,185 | N/A | -1,228 | N/A |
| Purchase Of Investment | -7,185 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -5,946 | -4,459 | -3,182 | N/A | -5,928 |
| Other Investing Activity | -5,946 | -4,459 | -3,182 | 0 | -5,928 |
| Investing Cash Flow | $194,906 | $99,797 | $-22,174 | $78,856 | $274,477 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 632,500 | 632,500 | 632,500 | N/A | N/A |
| Debt Repayment | -455,550 | -409,108 | -256,963 | N/A | N/A |
| Common Stock Issued | 101,317 | 101,316 | 99,394 | 7,760 | 52,036 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -90,548 |
| Other Financing Activity | -32,334 | -16,285 | -167,966 | -15,337 | -558,097 |
| Financing Cash Flow | $245,933 | $308,423 | $306,965 | $-7,577 | $-596,609 |
| Exchange Rate Effect | -111 | -43 | -22 | -126 | 617 |
| Beginning Cash Position | 397,664 | 397,664 | 397,664 | 397,664 | 683,287 |
| End Cash Position | 869,191 | 632,953 | 565,119 | 414,155 | 397,664 |
| Net Cash Flow | $471,527 | $235,289 | $167,455 | $16,491 | $-285,623 |
| Free Cash Flow | |||||
| Operating Cash Flow | 30,799 | -172,888 | -117,314 | -54,662 | 35,892 |
| Capital Expenditure | -11,955 | -9,453 | -6,130 | -1,772 | -35,120 |
| Free Cash Flow | 18,844 | -182,341 | -123,444 | -56,434 | 772 |